NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,351 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,351 Papers indexed
1,440 Papers AI scored
40,351 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-12 10:15 AM
1 Interventions to reduce paediatric cancer treatment abandonment in low-income and middle-income countries: a systematic review and meta-analysis. The Lancet. Global health — Nov 12, 2026 2 Paediatric cancer treatment abandonment: multifaceted solutions required. The Lancet. Global health — Nov 12, 2026 3 Conjunctival inflammatory myofibroblastic tumour in infancy: diagnostic challenges and sequential histopathological evolution. BMJ case reports — Nov 12, 2026 4 Genome-wide association study meta-analysis identifies susceptibility loci informing Ewing sarcoma etiology and potential mechanisms of risk. Cell genomics — Nov 12, 2026 5 Getting on the "same page": Couples' experiences communicating about hereditary cancer risk and family building decisions. Journal of psychosocial oncology — Nov 12, 2026 6 SPROUT Guidelines for Molecular Profiling for Children with Solid Tumors: A Consensus Recommendation from the American Association for Cancer Research. Clinical cancer research : an official journal of the American Association for Cancer Research — Nov 12, 2026 7 Association of medical play therapy with psychological resilience during chemotherapy in children with malignant lymphoma: a propensity score-weighted retrospective cohort study. Psychology, health & medicine — Nov 12, 2026 8 Expression patterns of hypoxia signaling pathway genes and their association with clinical biochemical parameters in acute myeloid leukemia patients of Assam: A case control study. Molecular biology reports — Nov 12, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40351 results
D
Assessment of the Effect of Brain Death Etiologies on Organs Transplanted Per Donor.
PMID 40094251 Published: 2025-02-01 Ingested: 2026-08-02 12:03 AM Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
AI -
Standard 40.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 40.3/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 24.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Mapping Support-Seeking After Cancer Treatment: A Co-Designed Model of Triggers, Timing and Support Pathways in Young People with Lived Experience of Cancer.
PMID 42505224 Published: 2026-07-15 Ingested: 2026-08-02 12:07 AM Current oncology (Toronto, Ont.)
AI -
Standard 40.24
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 40.2/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 26.2; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
New cell lines expanding the diversity of Ewing sarcoma models.
PMID 41002248 Published: 2025-09-26 Ingested: 2026-08-02 12:05 AM International journal of cancer
AI -
Standard 40.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 40.2/100. Study design: 35.0; human relevance: 20.0; therapeutic relevance: 26.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
The Kabuki Syndrome in 18 F-FDG-PET/CT.
PMID 40795805 Published: 2025-08-12 Ingested: 2026-08-02 12:05 AM Clinical nuclear medicine
AI -
Standard 40.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 40.2/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 36.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Interventional cytopathologist perspective on the Milan System Classification: a study on 929 consecutive salivary gland fine-needle aspirations with a focus on challenging diagnostic categories.
PMID 39748721 Published: 2024-12-01 Ingested: 2026-08-02 12:03 AM Pathologica
AI -
Standard 40.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 40.2/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 23.5; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Cost-effectiveness analysis of 9-valent human papillomavirus vaccine combined with screening for cervical cancer in Japan.
PMID 39731455 Published: 2024-12-28 Ingested: 2026-08-02 12:03 AM International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
AI -
Standard 40.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 40.2/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 23.5; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Experiences of a Digital Behavior Change Intervention to Prevent Weight Gain and Promote Risk-Reducing Health Behaviors for Women Aged 18 to 35 Years at Increased Risk of Breast Cancer: Qualitative Interview Study.
PMID 39586077 Published: 2024-11-25 Ingested: 2026-08-02 12:02 AM JMIR cancer
AI -
Standard 40.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 40.2/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 23.5; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Awareness of HPV and HPV vaccine among college students in China.
PMID 39360252 Published: 2024-09-18 Ingested: 2026-08-02 12:02 AM Frontiers in public health
AI -
Standard 40.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 40.2/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 23.5; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Cost-effectiveness of single-dose versus two-dose HPV vaccination: a Markov cohort modelling analysis of a Kenya-India LMIC composite.
PMID 42326956 Published: 2026-06-04 Ingested: 2026-08-02 12:06 AM Frontiers in public health
AI -
Standard 40.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 40.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

D
The situation of gynecological cancers in Thailand: incidence, histopathology, and survival outcomes from national cancer registry data.
PMID 41413786 Published: 2025-12-08 Ingested: 2026-08-02 12:05 AM Journal of gynecologic oncology
AI -
Standard 40.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 40.1/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

Previous
Page 3229 of 3363
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic